Relmada Therapeutics, Inc.

Other

Inturrisi, Charles E.

Manfredi, Paolo L.

Paolo L Manfredi

Charles E Inturrisi

Gilbert R Gonzales

The present invention relates to a method of treating psychiatric symptoms in a subject having a NMDA receptor and a NE receptor which includes administering d-methadone, d-methadol, d-alpha-acetylmethadol, l-alpha-acetylmethadol, d-alpha-normethadol, l-alpha-normethadol, pharmaceutically acceptable salts thereof, or mixtures thereof, to the subject under conditions effective for the substance to bind to the NMDA receptor and NE receptor of the subject.

d-methadone for the treatment of psychiatric symptoms

d-Methadone for the treatment of psychiatric symptoms

A pharmaceutical composition for administration to a patient body. The composition includes a physiologically-acceptable formulation including at least one active pharmaceutical ingredient, wherein said physiologically-acceptable formulation including said at least one active pharmaceutical ingredient is provided in a delivery form, said delivery form being administrable to a patient body through a plurality of administration routes, which include the oral and rectal routes.

Multi-site drug delivery platform

Growing community of inventors

New York, NY, United States of America

Paolo L Manfredi